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turnaround time for the result can be several days. The assay
itself takes ~4 hours, requiring relatively expensive
instrumentation and consumables including PCR primers,
enzymes and other reagents, which can be difficult to implement
in under-resourced health care systems. Collection of swab
samples for RT-PCR requires skilled health workers and close
face to face contact with patients; hence necessitating personal
protective equipment (PPE), which is expensive and may be in
short supply.[3] Nasal swab collection is uncomfortable,
sometimes even causing bleeding and is likely to be unacceptable
by some workers, where regular surveillance sampling is
required.[4] While saliva testing with RT-qPCR is being
explored[5], this does not overcome the limitations associated
with expense and time. Considering these many drawbacks, the
implementation of new diagnostic approaches that can be
performed rapidly, affordably, and with minimal risk to patient and
health care workers, is highly desirable.
Infrared spectroscopy is a routine analytical technique mainly
used to identify molecular functional groups in various materials.
Infrared light interacting with the intrinsic vibrational modes of
molecules generates a spectrum that represents a unique
chemical fingerprint of the sample. The development of portable
Attenuated Total Reflection Fourier Transform Infrared (ATRFTIR) spectrometers has seen a plethora of applications in the
field of biomedical diagnostics [6]. More recently, the technology
has been applied to diagnose Plasmodium sp. in blood [7] and
viruses including hepatitis B and hepatitis C in serum [8]. The
technique relies on detecting both the molecular phenotype of the
pathogen and the host immune response. Advanced machine
learning techniques can then be applied to predict diagnostic
outcomes based on the chemical differences between infected
and uninfected samples.

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) has resulted in an unprecedented need for diagnostic testing
that is critical in controlling the spread of COVID-19. We propose a
portable infrared spectrometer with purpose-built transflection
accessory for rapid point-of-care detection of COVID-19 markers in
saliva. Initially, purified virion particles were characterized with Raman
spectroscopy, synchrotron infrared (IR) and AFM-IR. A data set
comprising 171 transflection infrared spectra from 29 patients testing
positive for SARS-CoV-2 by RT-qPCR and 28 testing negative, was
modeled using Monte Carlo Double Cross Validation with 50
randomized test and model sets. The testing sensitivity was 93 %
(27/29) with a specificity of 82 % (23/28) that included positive
samples on the limit of detection for RT-qPCR. Here, we demonstrate
a proof-of-concept high throughput infrared COVID-19 test that is
rapid, inexpensive, portable and utilizes sample self-collection thus
minimizing the risk to healthcare workers and ideally suited to mass
screening.

Introduction
Coronavirus disease 2019 (COVID-19) is a highly transmissible
respiratory disease caused by the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). This virus has infected
over 160 million people resulting in greater than 3 million deaths
surpassing malaria infections as the world’s most devastating
infectious disease.[1] The high mortality rate and tremendous
socio-economic cost of the virus has necessitated mass testing to
detect infected individuals who can then be isolated to reduce
transmission. The gold standard for detection of SARS-CoV-2 is
reverse transcription Polymerize Chain Reaction (RT-PCR) assay
using material collected from nasopharyngeal swabs.[2] Whilst
the assay has been effective in reducing transmission rates, the

Figure 1. Schematic diagram of an infrared saliva-based test for COVID-19. (A-E) (A) Patient presents with COVID-19 symptoms. (B) The patient dribbles into
a container containing Viral Transport Medium (VTM). (C) The saliva, which contains a range of COVID-19 biomarkers including ACE2, adenosine deaminase,
immunoglobulin G, immunoglobulin M, RNA and secretory immunoglobulin A is deposited onto an infrared transflection substrate and dried (10 mins). (D) The
spectra were acquired in triplicate (5 minutes) using a PerkinElmer Spectrum Two spectrometer with a modified PerkinElmerÒ reflective accessory optimised for
transflection slides (insert). (E) The spectra, which represent a chemical snapshot of the entire saliva chemistry, including COVID-19 markers. (F) A Monte Carlo
double cross validation model is used to predict COVID-19 based on spectral markers. (G) The results are presented as PLS-DA prediction plots and Receiver
Operating Curves.
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Recently, Barauna et al.[9] applied ATR-FTIR to analyze saliva
collected from COVID-19 diagnosed patients using pharyngeal
swabs. In their measurements the swab was placed onto ATR
spectrometer and the spectrum recorded of both the saliva and
swab. Interestingly their spectra of purified virus did not show the
characteristic amide modes of proteins that are expected given
the dominant S-proteins that characterize SARS-CoV-2 virions,
nor did they show the characteristic RNA bands that would also
be expected from a large RNA virus. [10]
ATR spectroscopy has a number of disadvantages when it comes
to high throughput screening. First, the sample has to be dried
onto the internal reflection element (IRE) prior to the
measurement to maximise the absorbance. Secondly, the residue
must be cleaned off the IRE, which increases the potential of
transmission through aerosols and via surfaces, posing a danger
to the operator. More recently, ATR disposable silicon substrates
have been developed and deployed to detect brain cancer in
serum samples. [11] These substrates negate the drying and
cleaning steps but are prohibitively expensive for routine COVID19 testing at present. In pursuit of a cheaper approach to high
throughput screening, we propose utilizing infrared reflective
slides and a modified reflection accessory to obtain high quality
spectra of saliva. Hitherto, most infrared diagnostics have focused
on blood components and only few studies have investigated less
invasively collected samples such as saliva [12]. Saliva is
emerging as an attractive medium for point-of-care diagnosis of
COVID-19 in the current pandemic. The SARS-CoV-2 virus has a
preferential tropism to human airway epithelial cells that express
the cellular receptor angiotensin-converting enzyme 2 (ACE2)
[13]. ACE2 was found to be higher in salivary glands compared to
the lungs, indicating salivary glands could be a potential target for
SARS-CoV-2 [14]. Wylie et al. [15] reported that SARS-CoV-2
RNA copies were higher in saliva (5.58 mean log copies per
millilitre) compared to nasopharyngeal swabs (4.93 mean log
copies per millilitre) from 70 COVID-19 positive patients. Besides
SARS-CoV-2 virions, saliva is known to have many other COVID19 biomarkers, including ACE2, adenosine deaminase,
immunoglobulin G, immunoglobulin M, RNA and secretory
immunoglobulin A [16]. The number of potential biomarkers and
complexity of the spectra requires a machine modelling approach,
which has already been employed to data mine blood clinical
parameters for COVID-19 detection [17] and detecting SARSCoV-2 in nasal swabs using matrix-assisted laser
desorption/ionization-mass spectrometry (MALDI-MS). [18] From
a practical perspective, saliva can be self-collected by dribbling
into a sterile container reducing time and cost associated with the
specimen collection and minimising nosocomial transmission of
the disease [13b, 19]. The infrared technique is eminently suited
to the analysis of saliva samples because it requires no additional
reagents or consumables, is very rapid (less than 5 minutes to
record spectra from three replicate samples and do the
computation), the sample dries to a homogenous deposit and the
data can be directly transferred to a machine learning model for
diagnosis.

spectrum of the purified virus SARS-CoV-2 and assign the
important marker bands. The SARS-CoV-2 virions were purified
from the supernatant of infected Vero cells deactivated by fixation
with 4% formalin. [20] Aliquots from the purified stock solution
were deposited and dried onto a BaF2 window.
The presence of virions was confirmed by means of Transmission
Electron Microscopy (TEM). TEM images clearly show spherical
particles approximately 120 nm in diameter with multiple spikes
forming the solar crown structure, characteristic of coronaviruses
(Figure 2 A, B) [21]. This is consistent with previously reported
TEM images of SARS-CoV. [22] Atomic Force Microscopy (AFM)
confirmed the presence of spherical particles of approximately
120 nm in diameter, notably aggregated together in large clusters
(Figure 2 C, D). Synchrotron-FTIR spectra were collected from
the individual clusters and the mean and second derivative
spectrum calculated (Figure 2E).

Figure 2. AFM, TEM, synchrotron FTIR and Raman characterisation of
SARS-CoV-2 virus. (A-E) (A) TEM image of SARS-CoV-2 sample with single
virion marked by black square. (B) Magnification of the area marked by the black
square in (A), showing a single SARS-CoV-2 particle with its characteristic
morphological appearance. (C) AFM height and (D) AFM deflection images of
SARS-CoV-2 sample, demonstrating multiple round structures. The color scale
for (C) and (D) is provided below. (E) Synchrotron FTIR spectrum and its 2nd
derivative transform with the most prominent bands marked. (F) Raman
spectrum (532 nm) of SARS-CoV-2 virions (red) compared to spectrum of
purified RNA (black) with labelled bands. The bands are color-coded as follows:
lipids (blue), proteins (green) and nucleic acids (orange).

Numerous bands are observed, reflecting the main chemical
constituents of the virion particles (Table S1). These include
protein bands at 1657, 1547, 1517 cm-1 (from spike, envelope,
membrane and nucleocapsid proteins) along with lipid bands at
1740, 1464, 1382 and 1341 cm-1 (from lipid bilayer surrounding
the nucleocapsid). In particular, multiple bands associated with
RNA are present, including 1690, 1235, 1124, 1089, 996, 967 and
934 cm-1.[23] A similar spectral profile was observed using
nanoscale IR spectroscopy (Figure S1), which enables singlevirion spectra to be recorded at a vertical resolution of
approximately 100 nm. It is important to note that the spectra will
have minor contributions from fixative and residual media

Results and Discussion
A comprehensive schematic diagram of the COVID-19 diagnostic
approach is presented in Figure 1(A-G). In developing a new
infrared based test, the first aim was to record a high-quality
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attached to the virus particles. In particular, bands at 1235 cm-1
and 1092 cm-1 were assigned to residual paraformaldehyde,
which polymerizes when 4 % formalin dries (Figure S2). Raman
spectra of SARS-CoV-2 virions compared to purified RNA show
nucleic acid markers at 1242, 1110, 782, 723 and 670 cm-1 and
an RNA-specific marker band at 813 cm-1 (Figure 2F). Raman
spectroscopy confirms the purity of the virion extraction and
shows the very strong RNA bands that characterize this RNA rich
virus. The bands between 800-700 cm-1 are unique identifiers for
RNA as evidenced by the corresponding RNA spectrum, which
matches perfectly to many bands in the virion particle spectrum.
The lack of bands from media or fixative confirms the purity of the
virions. The relative contribution of RNA bands to the Raman
spectrum is very high, likely reflecting the very high content of
RNA in SARS-CoV-2, which contains the largest genome RNAcontaining viruses. In pursuit of a high throughput tool for pointof-care diagnosis, we optimized a PerkinElmer Spectrum Two
infrared spectrometer to perform transflection measurements
using a modified reflection accessory for infrared reflective slides.
A top plate was 3D printed to enable an aluminum slide holder to
be slid along the mount so that the background spectrum and
each sample deposit could be measured successively. To
improve the throughput the slides were mounted as low as
possible in the top plate and the mirrors of the reflection accessory
adjusted so the 8 mm beam matched the size of the deposit to
maximize absorbance. The larger infrared beam spot enables
more sample and consequently more virions to be detected in the
saliva compared to ATR-FTIR and Raman spectroscopy. Raman
has the advantage of being able to measure aqueous samples.
However, the diameter of laser beam (~1 µm) results in much less
virions being detected compared to the infrared based
approaches. Close up photographs of the accessory are found in
the Supporting Information (Figure S3). The transflection
approach resulted in greater absorbance compared to ATR and
less noise (Figure 3) because more sample is being interrogated
by the infrared beam and thus the ability to detect virions
improved. Other advantages include the ability to batch dry
samples; viral transmission is minimized by self-collection of
saliva with no swab contribution, the instrument does not need to
be cleaned between measurements, and the slides can be easily
stored for future analysis making the transflection approach more
conducive to point-of-site testing and mass screening compared
to ATR-FTIR. To test directly the application of the infrared
approach as a diagnostic for COVID-19 infection, we recorded
171 infrared spectra of triplicate dried saliva deposits from 57
human donors presenting to the Royal Melbourne Hospital with
COVID-19 like symptoms (Table S2). Of these 29 patients tested
positive with SARS-CoV-2 by RT-qPCR and 28 tested negative.
Figure 4A shows the averaged spectra (4000-800 cm-1) for the
positive and negative SARS-CoV-2 infected saliva samples along
with the corresponding second derivative spectra. Some of the
spectra show a small contribution from Viral Transport Medium
(VTM), which has bands at 1578 cm-1, 1408 cm-1 and 1078 cm-1
(Figure S4). In addition to signatures from infectious agents,
infrared spectra acquired from saliva will contain information from
components including mucins, proline-rich proteins, cystains,
histatins, statherins, amylases, carbonic anhydrases, salivary
peroxidases, lipids, carbohydrates and inorganic compounds
including nitrate and thiocyanate.[24] Saliva spectra have a
distinctive band from thiocyanate at 2059 cm-1 and strong bands
from proteins at 3288 cm-1, 1658 cm-1 and 1549 cm-1 assigned to

Figure 3. (A) Comparison of transflection spectra recorded using a Perkin Elmer
Spectrum Two FT-IR spectrometer by depositing and drying the saliva samples
(5 volunteers) directly onto the ATR internal reflection element (red) and using
the new transfection accessory with infrared transflection slides. (B) Signal-tonoise noise comparison between the two techniques showing standard
deviation error bars.

the amide A, amide I and II modes, respectively. The protein
bands on average appear more intense in the positive samples
compared to the negative samples. In general, the protein level of
saliva is relatively small compared to other biofluids like serum.
[24a] Hence, the significant difference in protein levels between
infected and uninfected samples would likely be from viral
proteins associated with the virus or antibodies produced by the
host. On average, the thiocyanate band appears slightly more
intense in the negative samples. Interestingly, thiocyanate is
converted by salivary peroxidases to hypothiocyanite (OSCN-1)
and is a potent antibacterial agent in the mouth, however, these
levels will also change in response to SCN-1 intake in food and
smoking [24b, 24c]. The bands at 1240 cm-1 and 1078 cm-1 are
assigned to the phosphodiester groups associated with nucleic
acids [23] and are more intense in the positive saliva samples
indicating a contribution from viral RNA to this band. However, the
1078 cm-1 band could also have minor contributions from VTM.
We first applied Principal Component Analysis (PCA) to
investigate general trends in the spectral data. The modelling was
performed in the phosphodiester region (1300-800 cm-1) on vector
normalized second derivative spectra where each spectrum is the
average of the three replicates (Source Data 1 and External
Modelling S1). The 1300-800 cm-1 region was chosen because
this is where many important RNA and glycoprotein marker bands
are located and there is less interference from VTM. The PC1 vs.
PC8 scores plot shows a general separation of infected and
uninfected saliva sample spectra along PC1 with most negatives
clustered in the lower left quadrant (Figure 4B). The
corresponding PC1 vector indicated a number of RNA bands
highlighted in orange (1237, 1121, 1078 and 940 cm-1)
distinguishing the positive from the negative samples (Figure 4C).
It should be noted that other bands including glycoproteins would
also contribute to these bands in this region of the spectrum but
the correlation with the averaged second derivative spectrum
shown of virion particles in Figure 2E indicates that the major
contribution to the infected saliva spectra is from RNA.
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Figure 5. MCDCV flow chart showing model architecture with inner cross
validation and outer prediction loops.

viral transport media in the sample, the more chance of finding
spurious correlations. Figure 4D shows the Receiver Operating
area under the ROC of 0.90, which is excellent for a small sample
cohort. The MCDCV modelling approach achieved a sensitivity of
93 % (27/29) and a specificity of 82 % (23/28) based on the
selection of a threshold of 0.6, which was optimized to reduce the
number of false-negatives (Figure 4E).

Figure 4. Patient modelling (A-E) (A) FTIR averaged spectra (bottom) and
corresponding second derivative transformed spectra (top) from 87 spectra from
29 COVID-19 positive patients (red) and 84 spectra from 28 COVID-19 negative
patients (blue) with important bands labelled. (B) Principal Component Analysis
(PCA) scores plot showing PC1 (54 % explained variance) and PC8 (2 %
explained variance) with each spectrum plotted as a single point in
multidimensional space with red dots associated with positive and blue dots
negative spectra. The red and blue shading shows the general separation of the
positive from negative spectra, which occurs along the diagonal. (C) PC1 and
PC8 loading plots showing the important bands discriminating the positive from
negative sample spectra along each PC. The positive scores are associated
with negative loadings and vice versa because the modelling was based on the
second derivative spectra. (D) Receiver Operating Characteristic (ROC) Curve
showing the false-positive rate versus the true positive rate for the MCDCV
model. (E) Probability diagram showing the averaged sample spectra plotted as
points in multi-dimensional space. The threshold value of 0.6 is shown by the
dotted line, which is optimized to minimize the number of false negatives
classified by the spectroscopic model. The error bars represent the standard
deviation for the 50 randomized test and model sets.

Conclusion
Here we report on a new transflection infrared based saliva test
for COVID-19. The results showed a 93 % sensitivity and 82 %
specificity using the MCDCV modelling approach. Furthermore,
we identified specific SARS-CoV-2 infrared and Raman marker
bands from highly purified virions. To improve the sensitivity and
specificity and determine if the technique has the specificity to
distinguish SARS-CoV-2 from other respiratory viruses including
influenza and other coronaviruses a larger patient cohort is
required. RNA RT-qPCR remains the “gold standard” diagnostic
technique for SARS-CoV-2 infection. However, there is an urgent
need for a point-of-care screening technique that could potentially
triage patients for specific RT-qPCR testing. Such a tool would be
extremely useful in the current pandemic enabling onsite
screening at airports, sporting venues, universities and schools.
An infrared based saliva test is logistically easier to perform, rapid,
and minimizes the risk of transmission to health workers.
Furthermore, self-collection of saliva would reduce patient
discomfort and improve community participation rates in testing.

Partial Least Squares-Discriminant Analysis (PLS-DA) was
employed to create discrimination models to predict the positivity
of the sample using first derivative spectra from the patient cohort
(Source Data 2 and External Modelling S2). The methodology
was evaluated using Monte Carlo Double Cross Validation
(MCDCV) with 50 randomized test (30 %) and model sets (70 %)
(Figure 5). The test spectra were averaged, and no test replicates
were included in the model avoiding over optimistic modelling, the
so-called technical replicate trap. By randomizing both the test
and model set ensures the most robust and unbiased way of
testing the model’s performance. Furthermore, by keeping the
numbers of variables small and using only the 1300-900 cm-1
region further increases the robustness of the modelling because
the more variables in the model, such as the variable amount of
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